干细胞移植的安全性分析  

Analysis of safety of stem cells transplantation

作　　者：胡菱[1] 韩明子[1] 薛洪璐[1] 景德怀[1] 

机构地区：[1]哈尔滨医科大学附属二院消化内科,黑龙江哈尔滨150086

出　　处：《胃肠病学和肝病学杂志》2011年第1期18-20,共3页Chinese Journal of Gastroenterology and Hepatology

摘　　要：干细胞移植治疗各种疾病的理论基础是干细胞具有自我更新及分化潜能,可以在体内或体外分化为各种组织细胞,有广阔的发展前景。但是近年一些研究发现干细胞移植可能导致微梗死、血栓性微血管病、肝静脉闭塞症及门静脉血栓形成及肿瘤等并发症。本文就干细胞临床移植可能面临的可行性及安全性问题进行了全面阐述。The theoretical basis of stem cell transplantation for treatment of various diseases is that stem cells have the potential ability of muti-directional differention and self-renewl,furthermore which can differentiate into various tissue cells in vivo and vitro.This has a bright prospct.However,in recent years,some studies show that stem cell transplantion could lead to a serious of complications,such as micro-infarction,thrombotic microangiopathy,hepatic venous occlusion disease,portal vein thrombosis,tumor,and so on.In this article,we focus on the safty and fesibility of stem cell transplantion which will be faced in future.

关 键 词：干细胞 微梗死 血栓性微血管病 肿瘤 移植 

分 类 号：Q813[生物学—生物工程]